about
Clinical significance of MET in gastric cancerPrognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancerImpact of comorbidities on postoperative complications in patients undergoing laparoscopy-assisted gastrectomy for gastric cancer.EphA4 is a prognostic factor in gastric cancer.Systematic review of anastomotic complications of esophagojejunostomy after laparoscopic total gastrectomy.Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer.CD49f(high) cells retain sphere-forming and tumor-initiating activities in human gastric tumorsPostoperative Complications of Laparoscopic Total Gastrectomy versus Open Total Gastrectomy for Gastric Cancer in a Meta-Analysis of High-Quality Case-Controlled Studies.Laparoscopic distal gastrectomy reduced surgical site infection as compared with open distal gastrectomy for gastric cancer in a meta-analysis of both randomized controlled and case-controlled studies.Therapeutic targeting of fibroblast growth factor receptors in gastric cancer.Preliminary experience using a computer-mediated flexible circular stapler in laparoscopic esophagogastrostomy.Laparoscopy-assisted gastrectomy in patients older than 80.Prognostic significance of PAK4 expression in gastric cancer.Prognostic value of tropomyosin-related kinases A, B, and C in gastric cancer.Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.Relation between outcomes and localisation of p-mTOR expression in gastric cancer.Effect of obesity on technical feasibility and postoperative outcomes of laparoscopy-assisted distal gastrectomy--comparison with open distal gastrectomy.Long-term comparison of laparoscopy-assisted distal gastrectomy and open distal gastrectomy in advanced gastric cancer.Clinical significance of platelet derived growth factor-C and -D in gastric cancer.[A case of advanced gastric cancer with a complete response to S-1 plus CPT-11 chemotherapy for eight years].[A case of advanced cancer of the gastric remnant with complete response to S-1 plus docetaxel chemotherapy as confirmed histopathologically].β-Shaped intracorporeal Roux-en-Y reconstruction after totally laparoscopic distal gastrectomy.Scoring system for evaluating functional disorders following laparoscopy-assisted distal gastrectomy.Vimentin expression is associated with decreased survival in gastric cancer.Erythropoietin-Producing Hepatocellular A1 is an Independent Prognostic Factor for Gastric Cancer.Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis.Clinical outcomes of laparoscopy-assisted gastrectomy for patients with heart disease.Feasibility of laparoscopy-assisted gastrectomy for patients with poor physical status: A propensity-score matching study.Long-term outcomes of Roux-en-Y and Billroth-I reconstruction after laparoscopic distal gastrectomy.Long- and short-term outcomes of laparoscopic gastrectomy versus open gastrectomy in patients with clinically and pathological locally advanced gastric cancer: a propensity-score matching analysis.Risk factors for post-operative pulmonary complications after gastrectomy for gastric cancer.Long-term effectiveness of preserved celiac branch of vagal nerve after Roux-en-Y reconstruction in laparoscopy-assisted distal gastrectomy.Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer.High expression of HER3 is associated with a decreased survival in gastric cancer.[Esophageal carcinoma - from the viewpoint of surgery][Second-line chemotherapy in gastric cancer following S-1 with CPT-11 chemotherapy performed as clinical trial]A comparison of Roux-en-Y and Billroth-I reconstruction after laparoscopy-assisted distal gastrectomyMethylated TMS1 and DAPK genes predict prognosis and response to chemotherapy in gastric cancerFunctional evaluation after vagus-nerve-sparing laparoscopically assisted distal gastrectomy[Current status and evaluation of laparoscopic surgery for gastric cancer]
P50
Q26776190-62B1B9E3-3A44-43EE-9E4A-97B50E9CA760Q33733751-BB152E4D-259A-4061-B3EE-C1DDF8211EDDQ34611474-8677F6BB-DF32-4276-A76A-A1F2DA230D7FQ34759687-66C6A74C-F32A-48A9-9607-EE0DD8200E89Q35992435-72720025-71A6-4ABD-B7E9-F580BFEE6C50Q36614109-7CFCA9BE-95DA-4CCA-BFB7-3CB56E11A307Q37129032-539DAB22-0BCD-40F5-B4AE-A3D584470FC0Q37500792-AEA0413E-0AA3-4BC4-9ABE-D29063368D8BQ38341534-3B9D1D04-6ECD-4313-A84E-A441EB3BC0C0Q38497265-D51CB2ED-5C5C-431B-9F85-D43F40A3B494Q39835586-A3EF9156-56BB-4CD6-BEC0-F58CFC51B3DEQ40386511-E61F9FDE-E992-46FF-81FA-E29761FBA074Q41091136-B425A506-757B-4AE9-9EB1-D0110AFCEC8CQ41231657-98C4849C-42B5-469B-9045-5959347EA6CAQ41693807-09C57D94-8CAB-423E-8DB6-217DAAC32166Q41926168-319E7FD7-1761-4A1A-B0BA-1B100808D0D4Q42635336-CA1FCBB6-43F3-49D8-B1C6-066C359677D9Q42663302-0312E93C-726E-44FB-A2E3-3D9EFDA79951Q43147517-6A085B95-218F-4163-8D73-4DDE4C83A47CQ43189400-2AC48B13-C57B-4C8C-A012-2F3327B45768Q43276286-A9282711-54F5-417E-B5D8-E2936EAA84A3Q43945259-48FF2995-722B-4E33-9A25-AE910518F532Q44358987-5591EFFB-6150-4254-853A-BC96EC98095FQ44492721-E88F1CF8-9538-44E1-991E-ED48BF4C0991Q44530924-201E27BB-FD61-4E5E-B975-2368B7ED0FC4Q44827496-8799790B-3C28-4958-A9CD-C3F01F3CCC93Q45762876-EDE92407-8DFF-42DB-AD28-33DFC5C7D28FQ47423699-EF6F9F7E-A6E7-4462-921D-F71F5F840B08Q47955190-C798690B-0979-4BD5-A68F-50FF6B90E845Q48097360-383C72C1-931F-4FA1-BBF0-0A1267BB04F8Q51725795-FAA024BD-9EC9-47D5-8550-302D47EC4131Q53662939-0A3B7698-F8C8-431F-90BA-EFD16FB4A72AQ54626959-27812002-A6F3-4022-9AB3-B000FBD88315Q54784314-968FD36D-B441-45C3-BF96-7199D3AAE1B3Q80470158-85E73688-F6FD-440F-96EB-C0D14EE57027Q80470175-5FF61171-1308-4E44-9EE4-2B8D16AB2DA0Q81386792-7AA66F68-4D97-4C41-A1F5-A21C98AB1DB9Q81456384-789CB9B9-C1A6-412E-BD7E-F8CBC8463DDDQ81564029-5C33C5EE-39FC-4D2A-9D26-F4B29916A3D6Q83152479-F17FFC40-ADE5-4BF5-B0F5-ACFFB45EB247
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mikito Inokuchi
@ast
Mikito Inokuchi
@en
Mikito Inokuchi
@es
Mikito Inokuchi
@fr
Mikito Inokuchi
@nl
Mikito Inokuchi
@sl
type
label
Mikito Inokuchi
@ast
Mikito Inokuchi
@en
Mikito Inokuchi
@es
Mikito Inokuchi
@fr
Mikito Inokuchi
@nl
Mikito Inokuchi
@sl
prefLabel
Mikito Inokuchi
@ast
Mikito Inokuchi
@en
Mikito Inokuchi
@es
Mikito Inokuchi
@fr
Mikito Inokuchi
@nl
Mikito Inokuchi
@sl
P106
P31
P496
0000-0001-7321-848X